Suchergebnisse - "ABCG2 protein, human"

PubPharm (2.862)

1

NAT10-mediated mRNA N4-acetylcytidine modification of MDR1 and BCRP promotes breast cancer progression

enthalten in: Thoracic cancer | 2024

von Zhao, C. | Sun, X. | Chen, J. | +1

2

Successful Prediction of Fetal Exposure to Dual BCRP/P-gp Drug Substrates Using the Efflux Ratio-Relative Expression Factor Approach and PBPK M&S

enthalten in: Clinical pharmacology and therapeutics | 2024

von Balhara, A. | Yin, M. | Unadkat, J.

3

The ABCG2 protein in vitro transports the xenobiotic thiabendazole and increases the appearance of its residues in milk

enthalten in: Environmental toxicology and pharmacology | 2024

von Álvarez-Fernández, L. | Blanco-Paniagua, E. | Millán-García, A. | +3

4

Magnolol derivatives as specific and noncytotoxic inhibitors of breast cancer resistance protein (BCRP/ABCG2)

enthalten in: Bioorganic chemistry | 2024

von da Silva Zanzarini, I. | Henrique Kita, D. | Scheiffer, G. | +12

5

Impacts of ABCG2 loss of function variant (p. Gln141Lys, c.421 C > A, rs2231142) on lipid levels and statin efficiency : a systematic review and meta-analysis

enthalten in: BMC cardiovascular disorders | 2024

von Liu, Y. | Chen, Y. | Wei, B. | +3

6

Extracellular Vesicles as Surrogates for the Regulation of the Drug Transporters ABCC2 (MRP2) and ABCG2 (BCRP)

enthalten in: International journal of molecular sciences | 2024

von Rigalli, J. | Gagliardi, A. | Diester, K. | +11

7

A novel ABCG2 variant causing Jr(a-) phenotype

enthalten in: Transfusion | 2024

von Kwon, S. | Yun, Y. | Kim, N. | +3

8

Tumor-acquired somatic mutation affects conformation to abolish ABCG2-mediated drug resistance

enthalten in: Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy | 2024

von Gose, T. | Rasouli, A. | Dehghani-Ghahnaviyeh, S. | +8

9

ABCG2 polymorphisms and susceptibility to ARV-associated hepatotoxicity

enthalten in: Molecular genetics & genomic medicine | 2024

von Singh, H. | Dhotre, K. | Shyamveer | +4

10

Foretinib, a c-MET receptor tyrosine kinase inhibitor, tackles multidrug resistance in cancer cells by inhibiting ABCB1 and ABCG2 transporters

enthalten in: Toxicology and applied pharmacology | 2024

von Nazari, S. | Mosaffa, F. | Poustforoosh, A. | +4

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[287]